How to spot unsupported peptide health claims

“Boosts recovery,” “reverses aging,” and “balances hormones” are not clinical endpoints. Ask what was measured, in whom, and against what comparison. If a page cites a laboratory mechanism, animal experiment, or testimonial, it has not shown that the product improves patient outcomes. FDA describes medication health fraud as marketing with unproven or misleading claims and warns that it can delay appropriate care. FDA: Common questions about medication health fraud

A company may cite an approved drug study while selling a different compound, route, or formula. Approval belongs to a specific product and indication, not to every item with a similar ingredient name. Drug Trials Snapshots and labels can show the population and original approval evidence for a named FDA-approved product. Ask for the study of the product actually proposed to you. If none exists, the claim needs to be described as uncertain. FDA: Drug Trials Snapshots

FDA registration, an NDC, a certificate of analysis, or a “pharmaceutical grade” phrase is not FDA approval. FDA explicitly states that registering an establishment and listing drugs does not mean FDA approved or verified the products. A pharmacy may legally compound a medicine for a qualifying patient, yet compounded drugs still do not receive FDA premarket approval. Require the seller to state the exact regulatory status. FDA: Drug registration and listing system FDA: Compounding and the FDA Q&A

A site promising a prescription before any clinician screening, hiding the pharmacy, or offering no post-purchase clinical contact deserves caution. FDA lists those practices among online GLP-1 telehealth red flags. Be skeptical of countdown timers and guaranteed outcomes. A serious provider can answer ordinary questions about evidence, risks, eligibility, and cost without pressuring you to buy immediately. FDA: Concerns with unapproved GLP-1 drugs

If an ad says “80% better,” ask 80% of what, compared with whom, over how long, and in how many participants. A change from baseline can sound dramatic while the control group changes too. Ask whether adverse effects and dropouts were included. A product page should link to the full study or current approved label, not only a cropped chart. ClinicalTrials.gov: Learn about studies

A legitimate medical decision should leave room to verify the clinician, pharmacy, and evidence. Limited-time offers, guaranteed prescriptions, or claims that “everyone needs peptides” encourage purchase before evaluation. If a site lists a large number of unrelated conditions for one product, ask for separate human evidence for each. FDA warns that unproven health claims can delay appropriate diagnosis and treatment; that delay may matter more than the money spent. FDA: Common questions about medication health fraud